Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells

Pancreatic ductal adenocarcinoma (PDAC) is well-known to be the most deadly malignancy with the worst survival rate of all cancers. Gemcitabine-based chemotherapy is the most common treatment option for pancreatic ductal adenocarcinoma. However, it offers little therapeutic value in many cases due t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Transl Res
Huvudupphovsmän: Huang, Bingfeng, Wang, Jianxin, Chen, Qi, Qu, Caidan, Zhang, Jian, Chen, Enjiang, Zhang, Yibo, Wang, Yi, Ni, Lei, Liang, Tingbo
Materialtyp: Artigo
Språk:Inglês
Publicerad: e-Century Publishing Corporation 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357319/
https://ncbi.nlm.nih.gov/pubmed/30788003
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk